SG11201602020QA - Polyethylene glycol-containing composition - Google Patents
Polyethylene glycol-containing compositionInfo
- Publication number
- SG11201602020QA SG11201602020QA SG11201602020QA SG11201602020QA SG11201602020QA SG 11201602020Q A SG11201602020Q A SG 11201602020QA SG 11201602020Q A SG11201602020Q A SG 11201602020QA SG 11201602020Q A SG11201602020Q A SG 11201602020QA SG 11201602020Q A SG11201602020Q A SG 11201602020QA
- Authority
- SG
- Singapore
- Prior art keywords
- polyethylene glycol
- containing composition
- composition
- glycol
- polyethylene
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dermatology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013195329 | 2013-09-20 | ||
| PCT/JP2014/074698 WO2015041294A1 (en) | 2013-09-20 | 2014-09-18 | Polyethylene glycol-containing composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201602020QA true SG11201602020QA (en) | 2016-04-28 |
Family
ID=52688941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201602020QA SG11201602020QA (en) | 2013-09-20 | 2014-09-18 | Polyethylene glycol-containing composition |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20160228420A1 (en) |
| EP (1) | EP3047850A4 (en) |
| JP (2) | JP5856264B2 (en) |
| KR (1) | KR20160060656A (en) |
| CN (1) | CN105555271A (en) |
| AU (1) | AU2014322111A1 (en) |
| BR (1) | BR112016006153A2 (en) |
| CA (1) | CA2924628A1 (en) |
| EA (1) | EA201690621A1 (en) |
| HK (2) | HK1220632A1 (en) |
| IL (1) | IL244648A0 (en) |
| MX (1) | MX2016003566A (en) |
| MY (1) | MY163236A (en) |
| PH (1) | PH12016500461A1 (en) |
| SG (1) | SG11201602020QA (en) |
| TW (1) | TW201518291A (en) |
| WO (1) | WO2015041294A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102538806B1 (en) | 2015-03-17 | 2023-05-31 | 산텐 세이야꾸 가부시키가이샤 | Pharmaceutical Compositions Containing Polypeptides |
| AR105947A1 (en) | 2015-03-18 | 2017-11-29 | Santen Pharmaceutical Co Ltd | OPTIONAL PHARMACEUTICAL COMPOSITION OF PROLONGED RELEASE AND METHOD TO STABILIZE A DRUG CONTAINED IN AN OPHTHALMIC DEPOSIT PREPARATION |
| JP2017008047A (en) * | 2015-06-25 | 2017-01-12 | 参天製薬株式会社 | Injectable agent |
| AR105215A1 (en) * | 2015-07-01 | 2017-09-13 | Santen Pharmaceutical Co Ltd | DEPOSIT FORMULATION CONTAINING ESTERS OF CITRUS ACID |
| CN106902117A (en) * | 2015-12-23 | 2017-06-30 | 瑞阳(苏州)生物科技有限公司 | A kind of medicine for preventing or treating CNV to be formed |
| EP3515444A4 (en) | 2016-09-26 | 2020-06-03 | Reyoung (Suzhou) Biology Science & Technology Co., Ltd | Composition for treating ocular diseases and methods of usage and making |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA833692B (en) * | 1982-05-28 | 1985-02-27 | Beecham Group Plc | Pharmaceutical formulations |
| JPS59101478A (en) * | 1982-11-29 | 1984-06-12 | Sunstar Inc | Water-based composition compounded stably with ligustilide |
| JPH09110698A (en) * | 1995-10-19 | 1997-04-28 | Taiho Yakuhin Kogyo Kk | Production of oral medicine composition |
| BRPI0507757A (en) | 2004-02-17 | 2007-07-10 | Santen Pharmaceutical Co Ltd | compound, pharmaceutical composition, and therapeutic agent for a disease in which angiogenesis or vascular hypermeability is involved. |
| CN1918127B (en) * | 2004-02-17 | 2012-02-15 | 参天制药株式会社 | New cyclocompound having 4-pyridylalkylthio group to which substituted or unsubstituted amino group is introduced |
| JP4626353B2 (en) * | 2004-02-17 | 2011-02-09 | 参天製薬株式会社 | Novel cyclic compound having a 4-pyridylalkylthio group having a substituted or unsubstituted amino group introduced |
| US20060153920A1 (en) * | 2004-09-24 | 2006-07-13 | Ketan Amin | Lyophilized pharmaceutical compositions |
| ES2564194T3 (en) * | 2005-02-09 | 2016-03-18 | Santen Pharmaceutical Co., Ltd. | Liquid formulations for the treatment of diseases or ailments |
| WO2007076358A1 (en) | 2005-12-23 | 2007-07-05 | Alcon, Inc. | PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE |
| AU2007356856A1 (en) | 2007-07-20 | 2009-01-29 | Alcon, Inc. | Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (RTKI) compounds to the eye |
| US8097266B2 (en) * | 2007-11-26 | 2012-01-17 | Merial Limited | Solvent systems for pour-on formulations for combating parasites |
| JP5583145B2 (en) | 2009-03-03 | 2014-09-03 | アルコン リサーチ， リミテッド | Pharmaceutical compositions for ocular delivery of receptor tyrosine kinase inhibitor (RTKi) compounds |
| MY157122A (en) * | 2009-07-17 | 2016-05-13 | Santen Pharmaceutical Co Ltd | 2 - [[[2 -[(hydroxyacetyl) amino]- 4 -pyridinyl] methyl]thio]- n -[4 - (trifluoromethoxy) phenyl]- 3 -pyridinecarboxamide benzene-sulfonate, crystal of same, polymorph thereof, and processes for production thereof |
| PT3158991T (en) * | 2010-01-28 | 2021-06-23 | Eagle Pharmaceuticals Inc | Formulations of bendamustine |
-
2014
- 2014-09-18 EP EP14845745.0A patent/EP3047850A4/en active Pending
- 2014-09-18 WO PCT/JP2014/074698 patent/WO2015041294A1/en active Application Filing
- 2014-09-18 AU AU2014322111A patent/AU2014322111A1/en not_active Abandoned
- 2014-09-18 JP JP2014190339A patent/JP5856264B2/en not_active Expired - Fee Related
- 2014-09-18 MY MYPI2016000477A patent/MY163236A/en unknown
- 2014-09-18 CA CA2924628A patent/CA2924628A1/en not_active Abandoned
- 2014-09-18 SG SG11201602020QA patent/SG11201602020QA/en unknown
- 2014-09-18 EA EA201690621A patent/EA201690621A1/en unknown
- 2014-09-18 US US15/023,207 patent/US20160228420A1/en not_active Abandoned
- 2014-09-18 CN CN201480051151.8A patent/CN105555271A/en active Pending
- 2014-09-18 KR KR1020167008149A patent/KR20160060656A/en not_active Application Discontinuation
- 2014-09-18 MX MX2016003566A patent/MX2016003566A/en unknown
- 2014-09-18 TW TW103132199A patent/TW201518291A/en unknown
- 2014-09-18 BR BR112016006153A patent/BR112016006153A2/en not_active IP Right Cessation
-
2015
- 2015-12-10 JP JP2015240775A patent/JP2016094442A/en active Pending
-
2016
- 2016-03-09 PH PH12016500461A patent/PH12016500461A1/en unknown
- 2016-03-17 IL IL244648A patent/IL244648A0/en unknown
- 2016-07-21 HK HK16108793.4A patent/HK1220632A1/en unknown
- 2016-08-11 HK HK16109575.6A patent/HK1221407A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1221407A1 (en) | 2017-06-02 |
| JP2016094442A (en) | 2016-05-26 |
| JP5856264B2 (en) | 2016-02-09 |
| MX2016003566A (en) | 2016-06-02 |
| WO2015041294A1 (en) | 2015-03-26 |
| EP3047850A1 (en) | 2016-07-27 |
| CN105555271A (en) | 2016-05-04 |
| CA2924628A1 (en) | 2015-03-26 |
| BR112016006153A2 (en) | 2017-08-01 |
| EP3047850A4 (en) | 2017-05-10 |
| MY163236A (en) | 2017-08-30 |
| EA201690621A1 (en) | 2016-07-29 |
| IL244648A0 (en) | 2016-04-21 |
| KR20160060656A (en) | 2016-05-30 |
| US20160228420A1 (en) | 2016-08-11 |
| PH12016500461A1 (en) | 2016-05-16 |
| HK1220632A1 (en) | 2017-05-12 |
| JP2015083565A (en) | 2015-04-30 |
| AU2014322111A1 (en) | 2016-04-07 |
| TW201518291A (en) | 2015-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3065569T3 (en) | Composition | |
| EP2889350A4 (en) | Tacky-adhesive composition | |
| HK1214088A1 (en) | Oil\fat composition | |
| HUE044039T2 (en) | Biocatalytical composition | |
| EP3006525A4 (en) | Asphalt-urethane composition | |
| GB201319540D0 (en) | Composition | |
| GB201318489D0 (en) | Composition | |
| GB201317388D0 (en) | Composition | |
| HK1221407A1 (en) | Polyethylene glycol-containing composition | |
| GB201320919D0 (en) | Composition | |
| EP3066178A4 (en) | Lumbricant composition | |
| GB201322772D0 (en) | Composition | |
| GB201319538D0 (en) | Composition | |
| GB201317105D0 (en) | Novel Composition | |
| GB201306984D0 (en) | Composition | |
| GB201320303D0 (en) | Composition | |
| GB201317196D0 (en) | Composition | |
| GB201307622D0 (en) | Composition | |
| GB201420672D0 (en) | Composition | |
| GB201308502D0 (en) | Composition | |
| GB201310513D0 (en) | Novel composition | |
| GB201301774D0 (en) | Composition | |
| GB201318394D0 (en) | Composition | |
| GB201320675D0 (en) | Composition | |
| GB201305622D0 (en) | Composition |